Standout Papers
Citation Impact
Citing Papers
Containment of Tumor-Colonizing Bacteria by Host Neutrophils
2008
A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules
2003 StandoutScience
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
2011
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
2014
Targeted Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia
2006
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2006
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Optimized Clostridium -Directed Enzyme Prodrug Therapy Improves the Antitumor Activity of the Novel DNA Cross-Linking Agent PR-104
2008
Anti–Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
2008
Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors
2009
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
2011
Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
2010
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
2009
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
2006
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Combinatorial Cancer Immunotherapy
2006
The Pathology and Genetics of Metastatic Pancreatic Cancer
2009
Pancreatic Ductal Adenocarcinoma
2012
Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation
1997
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
1997
Pancreatic cancer genomics
2014
Pancreatic cancer
2004 Standout
Inflammation and cancer
2002 StandoutNature
GM-CSF Gene-Modifed Cancer Cell Immunotherapies: Of Mice and Men
2006
A view on drug resistance in cancer
2019 StandoutNature
Necroptosis and its role in inflammation
2015 StandoutNature
Inflammatory networks and immune surveillance of pancreatic carcinoma
2013
Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region
1999
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
2010
Pancreatic cancer
2020 Standout
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
2013
Mouse models of pancreatic cancer
2004
The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery
2016
Oral delivery of tumor‐targeting Salmonella exhibits promising therapeutic efficacy and low toxicity
2009
Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy
1998
Can Laparoscopic Pancreaticoduodenectomy Be Safely Implemented?
2011
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Integrating liquid biopsies into the management of cancer
2017
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
2005
Differential and Epigenetic Gene Expression Profiling Identifies Frequent Disruption of the RELN Pathway in Pancreatic Cancers
2006
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Classification of Surgical Complications
2004 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance
2005
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
2014
Engineering the perfect (bacterial) cancer therapy
2010 Standout
Environmentally Controlled Invasion of Cancer Cells by Engineered Bacteria
2005
EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
2008
Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma
2009
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
2011 StandoutNature
Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays
2003
Pancreatic Adenocarcinoma
2014 Standout
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980–2007
2010
Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas
1999
Use of tumour-responsive T cells as cancer treatment
2009
Global cancer statistics
2011 Standout
Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor
2013
Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas
2006
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models
2007
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
2001
Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium
2009
Effect of Preoperative Biliary Decompression on Pancreaticoduodenectomy-Associated Morbidity in 300 Consecutive Patients
2001
Strategies for early detection of resectable pancreatic cancer
2014
Immunity, Inflammation, and Cancer
2010 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
2006
Outcomes of Adjuvant Chemoradiation After Pancreaticoduodenectomy With Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas
2009
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Cancer vaccines: between the idea and the reality
2003
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
2018
Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
2009
Cytokines in cancer pathogenesis and cancer therapy
2004
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Inflammation and the development of pancreatic cancer
2002
Cancer immunotherapy comes of age
2011 StandoutNature
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
Quality of Complication Reporting in the Surgical Literature
2002
Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion
2005
Primary brain tumours in adults
2003
Spinning molecular immunology into successful immunotherapy
2002
Total Laparoscopic Pancreaticoduodenectomy
2010
Adjuvant Chemoradiation Therapy for Adenocarcinoma of the Distal Pancreas
2010
Primary brain tumours in adults
2012 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Pancreatic Cancer
2010 Standout
Epidemiology of cholangiocarcinoma: An update focusing on risk factors
2009
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
2010
Androgen deprivation and radiation therapy: Sequencing studies using the shionogi in vivo tumor system
1997
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
2009
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro
2006
Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer
2010
Radiology of colorectal cancer
2002
Bacterial therapies: completing the cancer treatment toolbox
2008
Functional antibodies produced by oncolytic clostridia
2007
Pancreatic cancer: state-of-the-art care
2000
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer
1999
Cancer-related inflammation
2008 StandoutNature
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
1997
Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma
2010
One Thousand Consecutive Pancreaticoduodenectomies
2006
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
2009
Genetics and biology of pancreatic ductal adenocarcinoma
2006
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
2008
Head and Neck Cancer
2001 Standout
Pancreatic cancer
2011 Standout
Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy
2005
National Failure to Operate on Early Stage Pancreatic Cancer
2007
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
2004
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
2001
Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma
2007
Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer
2007
Comparison of Endoscopic Ultrasonography and Multidetector Computed Tomography for Detecting and Staging Pancreatic Cancer
2004
Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome
2002
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
2011 Science
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Prognostic Factors Associated with Resectable Adenocarcinoma of the Head of the Pancreas
1999
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Targeted Therapy with aSalmonella TyphimuriumLeucine-Arginine Auxotroph Cures Orthotopic Human Breast Tumors in Nude Mice
2006
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
2006
A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
2013
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
2009
Pronecrotic mixed lineage kinase domain‐like protein expression is a prognostic biomarker in patients with early‐stage resected pancreatic adenocarcinoma
2013
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities
2003
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
The Pancreas Cancer Microenvironment
2012
Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor.
1995 StandoutNobel
Adjuvant Treatment for Resectable Pancreatic Cancer
2005
Oxidative DNA damage: mechanisms, mutation, and disease
2003 Standout
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
2016
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
2008
Syndromes of Autoimmunity and Hypoglycemia: Autoantibodies Directed Against insulinand Its Receptor
1989
Effect of Hospital Volume and Experience on In-Hospital Mortality for Pancreaticoduodenectomy
2003
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
2012
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012
2020
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
2009
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
2012
The pathology and genetics of metastatic pancreatic cancer.
2009
Global cancer statistics, 2012
2015 Standout
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
2002
Immune Therapy for Cancer
2008
Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
2019
Pancreatic Cancer Genetic Epidemiology Consortium
2006
Engineered bidirectional communication mediates a consensus in a microbial biofilm consortium
2007 StandoutNobel
Dual-Phase Helical CT of Pancreatic Adenocarcinoma
2002
Epithelial to Mesenchymal Transition: Expression of the Regulators Snail, Slug, and Twist in Pancreatic Cancer
2007
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
2008
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
2004
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Laparoscopy in the staging of pancreatic cancer
2001
Works of Ross A. Abrams being referenced
Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
2009
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
2013
Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves Survival
1997
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
2008
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
1995
Should pancreaticoduodenectomy be performed in octogenarians?
1998
Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma—Part 3: Update on 5-Year Survival
2005
Increased Hepatic Oxidative DNA Damage in Patients with Hepatocellular Carcinoma
2001
Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
2000 Standout
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy
1996
Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12
2004
Differential methylation of cell‐free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis
2010
Radiotherapy Technical Considerations in the Management of Locally Advanced Pancreatic Cancer: American-French Consensus Recommendations
2012
Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
2008
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031
2010
Pancreatic cancer
2002
Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s
1997 Standout
Spiral CT of Colon Cancer: Imaging Features and Role in Management
2000
A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer
2012
Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas
2011
Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2
2002
Cholangiocarcinoma
1996
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels
1999
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas
1995
Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
2011
Pancreaticoduodenectomy
1996
A Phase I Clinical Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected with the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma. The Johns Hopkins Oncology Center, Baltimore, Maryland
1998
RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma
2006
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
2011
Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
2008
Treatment by Plasma Exchange of a Patient with Autoantibodies to the Insulin Receptor
1979
Correlation of RTOG 9704 (adjuvant therapy (rx) of pancreatic adenocarcinoma (pan ca)) radiation therapy quality assurance scores (RTQASc) with survival (S)
2007
Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation
2001
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
2003
Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study
2002
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
2001
146
2006
Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
2008
Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination
2003